import Link from "next/link";
import JsonLd from "@/components/JsonLd";
import PageDisclaimer from "@/components/PageDisclaimer";
import PageTOC from "@/components/PageTOC";
import ContactLink from "@/components/ContactLink";
import AmazonCTAButton from "@/components/AmazonCTAButton";
import { buildPageMetadata } from "@/lib/seo";

export const metadata = buildPageMetadata({
  path: "/supplements/coq10",
  title: "CoQ10: The Mitochondrial Cofactor With Heart Failure RCT Evidence",
  description:
    "CoQ10 dosing, ubiquinol vs ubiquinone, the Q-SYMBIO heart failure trial, and statin myopathy support. Plus how it stacks with MOTS-c and longevity peptides.",
});

const faqs = [
  {
    q: "Ubiquinol vs ubiquinone — which form should I take?",
    a: "Ubiquinol (the reduced, active antioxidant form) is meaningfully better absorbed than ubiquinone (the oxidized form), particularly in adults over 40 and in users with conditions that impair the conversion (statin therapy, chronic disease, mitochondrial dysfunction). For users under 35 with no metabolic concerns, ubiquinone is fine — your body converts it efficiently. For everyone else, ubiquinol is the practical default despite the higher per-mg cost. The Q-SYMBIO heart failure trial used ubiquinone successfully at 300 mg/day; the ubiquinol arm of trials uses lower doses (100–200 mg) for similar serum effects. Pick by age, condition, and budget — both forms work; ubiquinol is just more efficient.",
  },
  {
    q: "Should everyone on a statin take CoQ10?",
    a: "It's a reasonable case-by-case decision. Statins inhibit HMG-CoA reductase — the same enzyme upstream of endogenous CoQ10 synthesis — so chronic statin use does reduce CoQ10 levels. Whether this depletion meaningfully contributes to statin-induced myopathy (muscle pain) is debated; some trials show CoQ10 supplementation reduces statin myopathy, others show no effect. The cleanest practical heuristic: if you're on a statin and experiencing muscle pain or weakness, 100–200 mg/day ubiquinol for 8–12 weeks is a low-risk trial. If muscle symptoms improve, continue. If they don't, the muscle effects probably aren't CoQ10-driven and you should talk to your prescribing clinician.",
  },
  {
    q: "Does CoQ10 actually help heart failure?",
    a: "Yes, in the published trial base, with meaningful effect sizes. The Q-SYMBIO trial (Mortensen 2014, n=420, 2-year follow-up) found 300 mg/day CoQ10 significantly reduced major adverse cardiovascular events and cardiovascular mortality versus placebo in chronic heart failure patients. The KiSel-10 study (Alehagen 2013) found CoQ10 + selenium combined reduced cardiovascular mortality by 54% in elderly Swedish adults over 4 years. These are some of the strongest published cardiovascular-mortality outcome trials for any supplement. CoQ10 is one of the better-evidenced cardiac supplements — particularly in clinical heart failure populations.",
  },
  {
    q: "How long until I feel anything from CoQ10?",
    a: "Subjective effects, if any, emerge gradually over 4–8 weeks. CoQ10 isn't acute like caffeine; serum CoQ10 levels build over weeks of consistent dosing, and tissue concentrations follow more slowly. The clinical trials measured outcomes over 6 months to 4 years. If you're taking CoQ10 for cardiac or statin-myopathy reasons, evaluate at the 8–12 week mark, not the 2-week mark. If you're taking it for general anti-aging or longevity reasons, the effects are mostly biomarker-grade rather than subjectively perceptible.",
  },
  {
    q: "Can I stack CoQ10 with MOTS-c or NAD+ peptides?",
    a: (
      <>
        Yes — and the mechanism layering is mechanistically natural for users targeting mitochondrial function.{" "}
        <Link href="/peptides/mots-c" className="text-[#0891b2] hover:underline">MOTS-c</Link>{" "}
        is a mitochondrial-derived peptide that activates AMPK, increases insulin sensitivity, and supports mitochondrial biogenesis at the genetic/regulatory level.{" "}
        <Link href="/peptides/nad-plus" className="text-[#0891b2] hover:underline">NAD+ peptide</Link>{" "}
        delivers the essential cofactor for sirtuins and mitochondrial complex I activity. CoQ10 works at a different layer — it&apos;s the electron carrier between Complex I/II and Complex III in the electron transport chain, plus a fat-soluble antioxidant for mitochondrial membranes. The three converge on mitochondrial bioenergetics from different angles: MOTS-c on biogenesis and AMPK signaling, NAD+ on cofactor supply, CoQ10 on electron transport and membrane protection. Mechanistically additive, no known negative interactions.
      </>
    ),
  },
  {
    q: "How much CoQ10 should I take? 100 mg? 600 mg?",
    a: "Depends on goal. For general health and age-related CoQ10 decline (over 40): 100–200 mg/day of ubiquinol or 200–300 mg of ubiquinone. For statin-induced muscle pain: 100–200 mg/day ubiquinol. For heart failure or established cardiovascular disease (clinical adjunct, coordinate with cardiologist): 300–600 mg/day, the Q-SYMBIO dose range. For mitochondrial disease, fertility (egg/sperm quality), migraine prophylaxis: 300–400 mg/day. Higher than 600 mg/day rarely adds clinical benefit and is mostly wasted. Most users plateau on benefit above 400 mg/day.",
  },
  {
    q: "Does CoQ10 improve sperm or egg quality?",
    a: "Yes, with reasonable trial evidence in both male and female fertility. Multiple trials show CoQ10 supplementation improves sperm motility and concentration in subfertile men (200–400 mg/day for 3–6 months). Female fertility evidence is smaller but suggests improved ovarian response in older reproductive-age women, particularly during IVF cycles. The mechanism is mitochondrial — both eggs and sperm are exceptionally energy-demanding cells and sensitive to mitochondrial function. CoQ10 is one of the more evidence-supported fertility adjunct supplements for users over 35.",
  },
  {
    q: "Can I take CoQ10 with warfarin?",
    a: "Talk to your prescribing clinician — CoQ10 has a structural similarity to vitamin K and can mildly reduce warfarin&apos;s anticoagulant effect. The interaction is modest but real, and INR monitoring is the practical safeguard. Most patients can stay on both with appropriate INR adjustment; some prescribers prefer to avoid the combination. The interaction is well-documented and worth flagging at any anticoagulation clinic visit. Newer anticoagulants (apixaban, rivaroxaban) don&apos;t have this interaction.",
  },
];

const studies = [
  {
    title: "The Effect of Coenzyme Q10 on Morbidity and Mortality in Chronic Heart Failure: Results from Q-SYMBIO",
    authors: "Mortensen SA, Rosenfeldt F, Kumar A, et al.",
    journal: "JACC Heart Failure",
    year: "2014",
    access: "Open Access",
    url: "https://pubmed.ncbi.nlm.nih.gov/25282031/",
    summary: "A 2-year multicenter randomized double-blind placebo-controlled trial of CoQ10 (300 mg/day, ubiquinone) in 420 patients with moderate-to-severe chronic heart failure (NYHA III-IV). CoQ10 significantly reduced major adverse cardiovascular events (MACE) and cardiovascular mortality versus placebo, with parallel improvements in symptom severity. This is the largest and most-cited outcome trial for CoQ10 in heart failure and the trial that established CoQ10 as an evidence-supported adjunct in chronic heart failure care.",
  },
  {
    title: "Cardiovascular Mortality and N-Terminal-proBNP Reduced After Combined Selenium and Coenzyme Q10 Supplementation: A 5-Year Prospective Randomized Double-Blind Placebo-Controlled Trial",
    authors: "Alehagen U, Johansson P, Björnstedt M, et al.",
    journal: "International Journal of Cardiology",
    year: "2013",
    access: "Open Access",
    url: "https://pubmed.ncbi.nlm.nih.gov/22626835/",
    summary: "The KiSel-10 trial — a 4-year randomized double-blind placebo-controlled trial of CoQ10 (200 mg) plus selenium (200 mcg) in 443 elderly Swedish adults aged 70–88. The combination significantly reduced cardiovascular mortality by 54% and NT-proBNP biomarker versus placebo over the follow-up period. The trial is notable for the long follow-up duration, hard mortality endpoint, and elderly population — and provides some of the strongest published evidence for combined CoQ10/selenium supplementation in cardiovascular outcomes.",
  },
  {
    title: "The Effect of Coenzyme Q10 on Statin-Associated Muscle Symptoms: A Systematic Review and Meta-Analysis",
    authors: "Banach M, Serban C, Sahebkar A, et al.",
    journal: "Mayo Clinic Proceedings",
    year: "2015",
    access: "Open Access",
    url: "https://pubmed.ncbi.nlm.nih.gov/25636999/",
    summary: "A systematic review and meta-analysis of 6 RCTs (n=302) of CoQ10 supplementation in statin-associated muscle symptoms. The pooled analysis found significant reductions in muscle pain, muscle weakness, muscle cramps, and muscle tiredness with CoQ10 supplementation versus placebo. Effect sizes were modest. The Banach meta-analysis is the most-cited evidence summary supporting CoQ10 in statin myopathy — though other reviews have reached more cautious conclusions, the directional signal is consistently positive.",
  },
  {
    title: "Coenzyme Q10 Supplementation in Aging and Disease",
    authors: "Hernández-Camacho JD, Bernier M, López-Lluch G, Navas P",
    journal: "Frontiers in Physiology",
    year: "2018",
    access: "Open Access",
    url: "https://pubmed.ncbi.nlm.nih.gov/29459830/",
    summary: "A comprehensive review of CoQ10 biology and supplementation evidence across cardiovascular disease, neurodegenerative diseases (Parkinson's, Huntington's, ALS), mitochondrial diseases, statin myopathy, fertility, and chronic fatigue. Covers the ubiquinone-vs-ubiquinol bioavailability question, dose-response relationships, and age-related CoQ10 decline. Useful as a single-source reference for the CoQ10 evidence landscape and supplement decision-making.",
  },
  {
    title: "Coenzyme Q10 Supplementation in Sperm Parameters: A Systematic Review and Meta-Analysis",
    authors: "Lafuente R, González-Comadrán M, Solà I, et al.",
    journal: "Journal of Assisted Reproduction and Genetics",
    year: "2013",
    access: "Open Access",
    url: "https://pubmed.ncbi.nlm.nih.gov/23912751/",
    summary: "A meta-analysis of 3 RCTs (n=312) of CoQ10 supplementation in men with idiopathic infertility. CoQ10 significantly improved sperm concentration, motility, and morphology versus placebo. Effect sizes were modest but consistent across trials. The meta-analysis supports CoQ10 as an evidence-based male-fertility adjunct, particularly for subfertile men over 35 where mitochondrial function in sperm is age-relevant.",
  },
];

const sections = [
  {
    id: "mechanism",
    title: "How does CoQ10 work?",
    intro:
      "CoQ10 works through two parallel mechanisms that converge on cellular energy production and mitochondrial protection. As an essential mobile electron carrier in the mitochondrial electron transport chain, it shuttles electrons between Complex I/II and Complex III — without adequate CoQ10, ATP synthesis is impaired. As a fat-soluble antioxidant, it protects mitochondrial membranes, neuronal membranes, and circulating LDL from oxidative damage. Both arms are biochemically essential; both decline with age and with statin use.",
    body: [
      "Electron transport chain shuttle. CoQ10 (in both ubiquinone and ubiquinol forms) cycles between oxidized and reduced states as it carries electrons from Complex I and Complex II of the electron transport chain to Complex III. This electron flow generates the proton gradient across the inner mitochondrial membrane that drives ATP synthesis. CoQ10 deficiency directly impairs mitochondrial ATP production.",
      "Fat-soluble membrane antioxidant. Ubiquinol (the reduced form) is one of the few endogenous lipid-soluble antioxidants — it protects mitochondrial inner-membrane phospholipids, neuronal cell membranes, and circulating LDL particles from oxidative damage. It also regenerates vitamin E (α-tocopherol) and supports vitamin C recycling.",
      "Statin–CoQ10 interaction. Statins inhibit HMG-CoA reductase — the enzyme upstream of cholesterol synthesis AND of the mevalonate pathway that produces endogenous CoQ10. Chronic statin use reduces CoQ10 levels by 30–40%, contributing to statin-induced myopathy (muscle pain) in a subset of users. This is the strongest mechanistic case for CoQ10 supplementation in statin users.",
      "Cardiac tissue concentration. The heart has the highest CoQ10 concentration of any organ — reflecting cardiac muscle&apos;s extraordinary energy demand. CoQ10 depletion is implicated in cardiac dysfunction at the cellular bioenergetic level, which is the mechanistic basis for the heart-failure trial results.",
      "Age-related decline. Endogenous CoQ10 production declines with age, particularly after 40. Tissue concentrations drop in heart, skeletal muscle, and liver. Whether this decline drives age-related dysfunction or just accompanies it is debated; supplementation can correct the decline to younger-adult levels.",
    ],
  },
  {
    id: "research",
    title: "What does CoQ10 actually do?",
    intro:
      "CoQ10 has one of the strongest cardiovascular-outcomes RCT bases of any supplement. The Q-SYMBIO heart failure trial is particularly strong evidence — a hard-endpoint mortality trial with meaningful effect sizes. Secondary evidence covers statin myopathy, fertility, migraine prophylaxis, and neurodegenerative diseases. The general anti-aging case in healthy adults is weaker than the clinical-population case.",
    body: [
      "Heart failure outcomes (Strong). Q-SYMBIO (n=420, 2 years) demonstrated significant reductions in cardiovascular mortality and major adverse cardiovascular events with 300 mg/day in chronic heart failure. KiSel-10 (n=443, 4 years) showed combined CoQ10 + selenium reduced cardiovascular mortality 54% in elderly adults. Hard-endpoint outcomes data — unusually strong for a supplement.",
      "Statin-induced muscle symptoms (Moderate). Banach 2015 meta-analysis (6 RCTs, n=302) found significant reductions in muscle pain, weakness, cramps, and tiredness with CoQ10. Effect sizes are modest; not all trials show benefit; the clinical signal is consistently positive but not universally so.",
      "Sperm and egg quality (Moderate). Lafuente 2013 meta-analysis (3 RCTs, n=312) demonstrated significant improvements in sperm concentration, motility, and morphology. Female fertility evidence is smaller but suggests improved ovarian response in older reproductive-age women.",
      "Migraine prophylaxis (Moderate). Several RCTs show CoQ10 reduces migraine frequency by 25–30% with 300 mg/day for 3 months. Modest effect; reasonable adjunct in migraine management protocols.",
      "Neurodegenerative diseases (Mixed). Trials in Parkinson&apos;s disease, Huntington&apos;s, and ALS have shown mixed results — some positive signals, some null. Mechanistic rationale is strong; clinical efficacy is unresolved at the doses tested.",
      "Exercise performance and recovery (Weak/Modest). Small trials show reduced oxidative stress markers and modest endurance improvements. Effect sizes are small in trained athletes; larger in older or detrained populations.",
      "Healthy adult anti-aging (Weak). The case for asymptomatic healthy adults under 40 is mechanistically reasonable (replenishing age-related decline) but not directly RCT-validated for outcomes in this population.",
    ],
  },
  {
    id: "dosing",
    title: "How is CoQ10 dosed?",
    intro:
      "CoQ10 dosing depends on goal: general anti-aging maintenance is 100–200 mg/day; clinical conditions push 300–600 mg/day. The ubiquinol vs ubiquinone choice affects dose magnitude — ubiquinol is more bioavailable, so equivalent serum effects occur at roughly half the dose. Always take with fat (CoQ10 is fat-soluble; absorption is meaningfully dependent on dietary lipid coadministration).",
    node: (
      <div className="space-y-3">
        <ol className="list-decimal list-inside space-y-1">
          <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">General health / age-related maintenance.</span> 100–200 mg/day ubiquinol (or 200–300 mg ubiquinone) with the largest meal. Appropriate for adults over 40 wanting age-related CoQ10 replenishment.</li>
          <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Statin-induced muscle pain.</span> 100–200 mg/day ubiquinol for 8–12 weeks as a tolerance trial. If symptoms improve, continue; if not, the muscle issue likely isn&apos;t CoQ10-driven.</li>
          <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Heart failure / cardiovascular adjunct.</span> 300 mg/day ubiquinone (Q-SYMBIO protocol) or 200 mg/day ubiquinol. Coordinate with cardiologist — this is a clinical-adjunct dose, not a general-health dose.</li>
          <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Fertility / mitochondrial disease / migraine.</span> 300–400 mg/day, typically ubiquinol for older users. The dose range used in fertility trials and migraine prophylaxis studies.</li>
        </ol>
        <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed pt-2">
          Timeline: serum CoQ10 levels rise within days; tissue concentrations build over weeks; clinical effects emerge over 8–12 weeks. The Q-SYMBIO and KiSel-10 hard-endpoint effects took months to years to manifest. CoQ10 is a chronic-use supplement; acute dosing has no perceptible effect.
        </p>
        <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed pt-2">
          <span className="font-semibold">Label math.</span> &ldquo;CoQ10 200 mg&rdquo; typically means 200 mg of either ubiquinone or ubiquinol — read the label. Ubiquinol is roughly 2× more bioavailable than ubiquinone, so 100 mg ubiquinol ≈ 200 mg ubiquinone in serum terms. Most healthy users plateau above 400 mg/day total.
        </p>
      </div>
    ),
  },
  {
    id: "how-to-take",
    title: "How to take CoQ10",
    intro:
      "CoQ10 is taken orally as softgels (most common), capsules, tablets, or sometimes liquid. The dominant practical concern is absorption — CoQ10 is highly fat-soluble, and absorption with food (especially fat-containing meals) is meaningfully better than empty-stomach dosing. Form choice (ubiquinol vs ubiquinone) is the second-biggest decision.",
    node: (
      <div className="space-y-4">
        <div className="overflow-x-auto -mx-4 sm:mx-0">
          <table className="w-full text-base text-left border-collapse border border-gray-200 dark:border-slate-700 rounded-lg overflow-hidden">
            <thead className="bg-gray-100 dark:bg-[#1e2d3d]">
              <tr>
                <th className="px-4 py-3 font-semibold text-[#1e2d3d] dark:text-slate-100">Aspect</th>
                <th className="px-4 py-3 font-semibold text-[#1e2d3d] dark:text-slate-100">Recommendation</th>
              </tr>
            </thead>
            <tbody className="divide-y divide-gray-200 dark:divide-slate-700">
              <tr className="even:bg-gray-50 dark:even:bg-[#1e293b]/50">
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300 font-medium">Frequency</td>
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300">Once daily for doses up to 200 mg; split twice daily (AM + PM) for higher doses (300 mg+) — improves serum profile over single large dose.</td>
              </tr>
              <tr className="even:bg-gray-50 dark:even:bg-[#1e293b]/50">
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300 font-medium">Best time of day</td>
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300">With the largest fat-containing meal of the day — typically breakfast or dinner. Coffee + bulletproof or fat-containing breakfast is ideal for single dosing.</td>
              </tr>
              <tr className="even:bg-gray-50 dark:even:bg-[#1e293b]/50">
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300 font-medium">Food</td>
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300">ALWAYS with fat. CoQ10 absorption is meaningfully impaired without dietary fat coadministration. Empty-stomach dosing wastes ~70% of the dose.</td>
              </tr>
              <tr className="even:bg-gray-50 dark:even:bg-[#1e293b]/50">
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300 font-medium">Form</td>
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300">Softgels in oil base are the practical default (best absorption). Ubiquinol for adults over 40, statin users, and clinical contexts; ubiquinone is fine for users under 35 with no impaired-conversion factors. Powder/capsule forms work but require strict with-fat dosing.</td>
              </tr>
              <tr className="even:bg-gray-50 dark:even:bg-[#1e293b]/50">
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300 font-medium">Standardization marker</td>
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300">Look for &ldquo;Kaneka ubiquinol&rdquo; (the dominant pharmaceutical-grade ubiquinol manufacturer) or USP-grade ubiquinone with mg per serving explicitly disclosed. Avoid proprietary blends that obscure the actual CoQ10 dose.</td>
              </tr>
              <tr className="even:bg-gray-50 dark:even:bg-[#1e293b]/50">
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300 font-medium">Cycling</td>
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300">No cycling needed — chronic daily use is the trial-validated model. The Q-SYMBIO protocol was 2 years continuous; KiSel-10 was 4 years.</td>
              </tr>
            </tbody>
          </table>
        </div>
      </div>
    ),
  },
  {
    id: "stacks",
    title: "What does CoQ10 stack with?",
    intro:
      "CoQ10 pairs naturally with the broader mitochondrial-bioenergetics and cardiovascular toolkit. The mechanism is mitochondrial electron transport + membrane antioxidant, which complements peptides operating on mitochondrial biogenesis (MOTS-c), NAD+ supply (NAD+ peptide), and other longevity-stack components. The three areas below cover the natural stacking categories.",
    node: (
      <div className="space-y-5">
        <div>
          <h3 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">With peptides</h3>
          <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
            CoQ10 pairs naturally with the mitochondrial peptide cluster.{" "}
            <Link href="/peptides/mots-c" className="text-[#0891b2] hover:underline">MOTS-c</Link>{" "}
            is a mitochondrial-derived peptide that activates AMPK, improves insulin sensitivity, and supports mitochondrial biogenesis at the regulatory/genetic level.{" "}
            <Link href="/peptides/nad-plus" className="text-[#0891b2] hover:underline">NAD+ peptide</Link>{" "}
            delivers NAD+ — the cofactor for sirtuins and the electron donor for Complex I of the electron transport chain. CoQ10 operates at a different layer: it&apos;s the electron carrier between Complex I/II and Complex III, plus a fat-soluble antioxidant for mitochondrial membranes. The three converge on mitochondrial function from different angles — MOTS-c on biogenesis and signaling, NAD+ on cofactor supply, CoQ10 on electron transport and membrane protection. Mechanistically additive, no known negative interactions. Introduce one variable at a time when starting a new stack so you can tell what&apos;s actually doing what.
          </p>
        </div>
        <div>
          <h3 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">With supplements</h3>
          <ol className="list-decimal list-inside space-y-1">
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
              <Link href="/supplements/nmn" className="text-[#0891b2] hover:underline">NMN</Link>{" "}
              — oral NAD+ precursor. Pairs cleanly with CoQ10&apos;s electron-transport mechanism; both support mitochondrial ATP production from different angles.
            </li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
              <Link href="/supplements/spermidine" className="text-[#0891b2] hover:underline">Spermidine</Link>{" "}
              — autophagy and mitophagy activator. Clears damaged mitochondria; CoQ10 supports the remaining functional ones. Mechanistically complementary.
            </li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
              <Link href="/supplements/fish-oil" className="text-[#0891b2] hover:underline">Omega-3 fish oil</Link>{" "}
              — cardiovascular and membrane fluidity support. The KiSel-10 evidence is for CoQ10 + selenium specifically, but omega-3 is a common co-occupant in cardiovascular supplement protocols.
            </li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
              Selenium (200 mcg/day) — the KiSel-10 trial used CoQ10 + selenium combined. If you&apos;re using CoQ10 for cardiovascular outcomes, selenium is the evidence-paired adjunct.
            </li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
              <Link href="/supplements/resveratrol" className="text-[#0891b2] hover:underline">Resveratrol</Link>{" "}
              — sirtuin activator and antioxidant. Compatible longevity-stack co-occupant.
            </li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
              <Link href="/supplements/magnesium" className="text-[#0891b2] hover:underline">Magnesium</Link>{" "}
              — cofactor for over 300 enzymes including those in mitochondrial energy metabolism. Common deficiency; supports the system CoQ10 operates within.
            </li>
          </ol>
        </div>
        <div>
          <h3 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">With lifestyle</h3>
          <ol className="list-decimal list-inside space-y-1">
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Always with fat-containing meals.</span> CoQ10 absorption is meaningfully fat-dependent. Take with the largest fat-containing meal of the day. Empty-stomach dosing wastes most of the dose.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Regular endurance exercise.</span> Exercise increases CoQ10 demand and may amplify benefit; CoQ10 reduces exercise-induced oxidative stress in some trials.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Statin coordination.</span> If you&apos;re on a statin, CoQ10 supplementation is one of the cleanest case-by-case adjunct decisions — particularly if experiencing muscle symptoms.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Anticoagulation monitoring.</span> If on warfarin, monitor INR for the first 4–6 weeks of CoQ10 use — modest interaction documented.</li>
          </ol>
        </div>
      </div>
    ),
  },
  {
    id: "side-effects",
    title: "Side effects and interactions",
    intro:
      "CoQ10 has one of the cleanest safety profiles of any cardiovascular supplement. Decades of clinical use, no established Tolerable Upper Intake Level, no documented serious adverse events at supplemental doses. The main practical considerations are mild GI effects, blood-pressure-lowering at high doses, and the warfarin interaction.",
    node: (
      <div className="space-y-5">
        <div>
          <h3 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">Common (mostly transient)</h3>
          <ol className="list-decimal list-inside space-y-1">
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Mild GI discomfort — occasional nausea or stomach upset, especially on empty stomach. Resolves with food coadministration.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Heartburn or reflux — uncommon, occasionally reported at higher doses (300 mg+).</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Mild fatigue or dizziness — rare, typically dose-related.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">No documented serious adverse events at supplemental doses across the human RCT base (decades of use).</li>
          </ol>
        </div>
        <div>
          <h3 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">Less common (watch-list)</h3>
          <ol className="list-decimal list-inside space-y-1">
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Mild blood-pressure reduction — relevant if you&apos;re on antihypertensive medications; modest additive effect. Monitor BP during the first 4–6 weeks of use.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Insomnia — occasionally reported with evening dosing; switch to morning dose if affected.</li>
          </ol>
        </div>
        <div>
          <h3 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">Drug and supplement interactions</h3>
          <ol className="list-decimal list-inside space-y-1">
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Warfarin.</span> CoQ10 has structural similarity to vitamin K and can mildly reduce warfarin&apos;s anticoagulant effect. Modest but documented interaction; monitor INR during the first 4–6 weeks of combined use. Newer anticoagulants (apixaban, rivaroxaban) don&apos;t have this interaction.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Statins.</span> No negative interaction — in fact, statins deplete CoQ10 and CoQ10 supplementation may mitigate statin myopathy. Generally a beneficial coadministration.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Antihypertensive medications.</span> CoQ10 modestly lowers blood pressure; additive effect with BP medications. Monitor during titration.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Chemotherapy — some cancer treatments (doxorubicin) deplete CoQ10 and supplementation may protect cardiac function. Coordinate with oncologist.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Pregnancy — limited data; defer to clinician for supplemental dosing during pregnancy.</li>
          </ol>
        </div>
      </div>
    ),
  },
  {
    id: "limitations",
    title: "What we don't know yet about CoQ10",
    intro:
      "CoQ10 has one of the deeper supplement evidence bases in cardiovascular and statin-myopathy contexts. Several open questions remain — particularly around population specificity, optimal form (ubiquinol vs ubiquinone), and the benefit gap between clinical and healthy populations.",
    node: (
      <div className="space-y-3">
        <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          <span className="font-semibold">Healthy-adult primary prevention.</span> The strongest CoQ10 evidence is in established heart failure, cardiovascular disease, and statin myopathy populations. Whether CoQ10 prevents cardiovascular events in metabolically healthy adults is much less directly studied. The KiSel-10 trial in elderly Swedish adults provides some primary-prevention signal, but the evidence base in healthy adults under 65 is weak.
        </p>
        <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          <span className="font-semibold">Ubiquinol vs ubiquinone head-to-head outcomes.</span> Ubiquinol is more bioavailable, particularly in older adults — but most outcome trials (Q-SYMBIO, KiSel-10) used ubiquinone. Whether ubiquinol produces larger outcome effects at equivalent serum levels is mechanistically reasonable but not directly RCT-tested for hard endpoints.
        </p>
        <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          <span className="font-semibold">Statin-myopathy efficacy variability.</span> Banach 2015 meta-analysis is positive; other reviews are more cautious. Not all statin users with muscle symptoms respond to CoQ10. Whether the responder subgroup can be identified ahead of time isn&apos;t resolved.
        </p>
        <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          <span className="font-semibold">Neurodegenerative diseases.</span> Mechanistic case is strong (mitochondrial dysfunction is implicated in Parkinson&apos;s, Huntington&apos;s, ALS), but clinical trial results have been disappointing. Whether higher doses, different formulations, or earlier intervention would show effect is open.
        </p>
        <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          <span className="font-semibold">Optimal dose-response curve.</span> Most healthy users plateau on benefit above 400 mg/day; the Q-SYMBIO 300 mg arm produced the cardiac outcomes. Whether higher doses (600–1200 mg) produce additional clinical benefit is poorly characterized.
        </p>
        <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          <span className="font-semibold">Multi-year safety at high doses.</span> Q-SYMBIO ran 2 years at 300 mg/day; KiSel-10 ran 4 years at 200 mg/day. Multi-decade use at 400+ mg/day is not characterized in controlled trials — though the safety profile of long-term moderate dosing is reassuring.
        </p>
      </div>
    ),
  },
  {
    id: "where-to-buy",
    title: "Where to buy CoQ10",
    intro:
      "CoQ10 is widely available over-the-counter from supplement retailers. Quality varies considerably — particularly around form (ubiquinol vs ubiquinone), oil-base formulation for absorption, and dose disclosure. The quality markers below are the screen we use before clicking through.",
    node: (
      <div className="space-y-4">
        <div className="rounded-xl p-5 bg-gray-50 dark:bg-[#1e293b] border border-gray-100 dark:border-slate-700">
          <p className="text-xs font-semibold uppercase tracking-wider text-gray-500 dark:text-slate-400 mb-3">Quality markers to look for</p>
          <ul className="list-disc list-inside space-y-1">
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Kaneka ubiquinol or Kaneka Q10</span> — the dominant pharmaceutical-grade CoQ10 manufacturer; their trademarks signal the trial-validated raw material.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Softgels in oil base</span> — meaningfully better absorption than dry capsules or tablets for fat-soluble CoQ10.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Form explicitly disclosed</span> — &ldquo;ubiquinol&rdquo; (reduced, more bioavailable) or &ldquo;ubiquinone&rdquo; (oxidized, less bioavailable but cheaper). Ubiquinol preferred for adults over 40 and statin users.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">100–200 mg per serving</span> (the practical baseline dose); higher doses for clinical use coordinated with clinician.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Third-party tested</span> — USP, NSF, or ConsumerLab certifications signal independent verification.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">cGMP-certified manufacturing facility</span> — minimum bar for any supplement.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">No proprietary blends</span> that obscure the actual CoQ10 dose alongside fillers.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Cool, light-protected storage on retailer side</span> — CoQ10 degrades with prolonged exposure to heat and light. Avoid jars sitting on warm shelves &gt;18 months pre-purchase.</li>
          </ul>
        </div>
        <AmazonCTAButton href="https://www.amazon.com/s?k=CoQ10+ubiquinol&tag=profpeptide-20" label="CoQ10" />
        <p className="text-sm text-gray-500 dark:text-slate-400 leading-relaxed">
          Amazon affiliate link — Prof. Peptide earns a small commission on qualifying purchases at no extra cost to you. We use commissions to fund research and editorial work.
        </p>
      </div>
    ),
  },
  {
    id: "faq",
    title: "CoQ10 FAQ",
    node: (
      <div className="space-y-4">
        {faqs.map((f, i) => (
          <div key={i}>
            <h3 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-1">
              {f.q}
            </h3>
            <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
              {f.a}
            </p>
          </div>
        ))}
      </div>
    ),
  },
  {
    id: "references",
    title: "References",
    node: (
      <ol className="list-decimal list-inside space-y-2">
        <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          Mortensen SA, Rosenfeldt F, Kumar A, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO. JACC Heart Fail. 2014;2(6):641-649.{" "}
          <a href="https://pubmed.ncbi.nlm.nih.gov/25282031/" target="_blank" rel="noopener noreferrer" className="text-[#0891b2] hover:underline break-words">
            https://pubmed.ncbi.nlm.nih.gov/25282031/
          </a>
        </li>
        <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          Alehagen U, Johansson P, Björnstedt M, et al. Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled trial. Int J Cardiol. 2013;167(5):1860-1866.{" "}
          <a href="https://pubmed.ncbi.nlm.nih.gov/22626835/" target="_blank" rel="noopener noreferrer" className="text-[#0891b2] hover:underline break-words">
            https://pubmed.ncbi.nlm.nih.gov/22626835/
          </a>
        </li>
        <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          Banach M, Serban C, Sahebkar A, et al. Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials. Mayo Clin Proc. 2015;90(1):24-34.{" "}
          <a href="https://pubmed.ncbi.nlm.nih.gov/25636999/" target="_blank" rel="noopener noreferrer" className="text-[#0891b2] hover:underline break-words">
            https://pubmed.ncbi.nlm.nih.gov/25636999/
          </a>
        </li>
        <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          Lafuente R, González-Comadrán M, Solà I, et al. Coenzyme Q10 and male infertility: a meta-analysis. J Assist Reprod Genet. 2013;30(9):1147-1156.{" "}
          <a href="https://pubmed.ncbi.nlm.nih.gov/23912751/" target="_blank" rel="noopener noreferrer" className="text-[#0891b2] hover:underline break-words">
            https://pubmed.ncbi.nlm.nih.gov/23912751/
          </a>
        </li>
        <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          Hernández-Camacho JD, Bernier M, López-Lluch G, Navas P. Coenzyme Q10 supplementation in aging and disease. Front Physiol. 2018;9:44.{" "}
          <a href="https://pubmed.ncbi.nlm.nih.gov/29459830/" target="_blank" rel="noopener noreferrer" className="text-[#0891b2] hover:underline break-words">
            https://pubmed.ncbi.nlm.nih.gov/29459830/
          </a>
        </li>
        <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          Sandor PS, Di Clemente L, Coppola G, et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology. 2005;64(4):713-715.{" "}
          <a href="https://pubmed.ncbi.nlm.nih.gov/15728298/" target="_blank" rel="noopener noreferrer" className="text-[#0891b2] hover:underline break-words">
            https://pubmed.ncbi.nlm.nih.gov/15728298/
          </a>
        </li>
      </ol>
    ),
  },
  {
    id: "studies",
    title: "Published Studies",
    node: (
      <div className="space-y-6">
        <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          Plain-English summaries of the peer-reviewed studies behind the claims above. Click any title to read the source paper.
        </p>
        {studies.map((s, i) => (
          <div key={i} className="border border-gray-100 dark:border-slate-700 rounded-xl p-5 hover:border-[#0891b2] transition-colors">
            <div className="flex flex-wrap items-center gap-2 mb-2">
              <span className="text-xs text-gray-400 dark:text-slate-500">{s.journal} &middot; {s.year}</span>
              <span className={`text-xs px-2 py-0.5 rounded-full font-medium ${s.access === "Open Access" ? "bg-green-50 text-green-700 border border-green-200" : "bg-gray-100 dark:bg-slate-700 text-gray-500 dark:text-slate-400"}`}>{s.access}</span>
            </div>
            <a href={s.url} target="_blank" rel="noopener noreferrer" className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 hover:text-[#0891b2] transition-colors leading-snug block mb-1">{s.title} &rarr;</a>
            <p className="text-xs text-gray-400 dark:text-slate-500 mb-3">{s.authors}</p>
            <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">{s.summary}</p>
          </div>
        ))}
      </div>
    ),
  },
];

const tocSections = sections.map((s) => ({ id: s.id, title: s.title }));

const faqPageSchema = {
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "Ubiquinol vs ubiquinone — which form should I take?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Ubiquinol (the reduced, active antioxidant form) is meaningfully better absorbed than ubiquinone (the oxidized form), particularly in adults over 40 and in users with conditions that impair the conversion (statin therapy, chronic disease, mitochondrial dysfunction). For users under 35 with no metabolic concerns, ubiquinone is fine — your body converts it efficiently. For everyone else, ubiquinol is the practical default despite the higher per-mg cost."
      }
    },
    {
      "@type": "Question",
      "name": "Should everyone on a statin take CoQ10?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "It's a reasonable case-by-case decision. Statins inhibit HMG-CoA reductase — the same enzyme upstream of endogenous CoQ10 synthesis — so chronic statin use does reduce CoQ10 levels. Whether this depletion meaningfully contributes to statin-induced myopathy is debated; some trials show CoQ10 supplementation reduces statin myopathy, others show no effect. If you're on a statin and experiencing muscle pain or weakness, 100–200 mg/day ubiquinol for 8–12 weeks is a low-risk trial."
      }
    },
    {
      "@type": "Question",
      "name": "Does CoQ10 actually help heart failure?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes, in the published trial base, with meaningful effect sizes. The Q-SYMBIO trial (Mortensen 2014, n=420, 2-year follow-up) found 300 mg/day CoQ10 significantly reduced major adverse cardiovascular events and cardiovascular mortality versus placebo in chronic heart failure patients. The KiSel-10 study (Alehagen 2013) found CoQ10 + selenium combined reduced cardiovascular mortality by 54% in elderly Swedish adults over 4 years."
      }
    },
    {
      "@type": "Question",
      "name": "How long until I feel anything from CoQ10?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Subjective effects, if any, emerge gradually over 4–8 weeks. CoQ10 isn't acute like caffeine; serum CoQ10 levels build over weeks of consistent dosing, and tissue concentrations follow more slowly. The clinical trials measured outcomes over 6 months to 4 years. If you're taking CoQ10 for cardiac or statin-myopathy reasons, evaluate at the 8–12 week mark, not the 2-week mark."
      }
    },
    {
      "@type": "Question",
      "name": "Can I stack CoQ10 with MOTS-c or NAD+ peptides?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes — and the mechanism layering is mechanistically natural for users targeting mitochondrial function. MOTS-c is a mitochondrial-derived peptide that activates AMPK, increases insulin sensitivity, and supports mitochondrial biogenesis at the genetic/regulatory level. NAD+ peptide delivers the essential cofactor for sirtuins and mitochondrial complex I activity. CoQ10 works at a different layer — it's the electron carrier between Complex I/II and Complex III in the electron transport chain, plus a fat-soluble antioxidant for mitochondrial membranes. Mechanistically additive."
      }
    },
    {
      "@type": "Question",
      "name": "How much CoQ10 should I take?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Depends on goal. For general health and age-related CoQ10 decline (over 40): 100–200 mg/day of ubiquinol or 200–300 mg of ubiquinone. For statin-induced muscle pain: 100–200 mg/day ubiquinol. For heart failure or established cardiovascular disease (clinical adjunct): 300–600 mg/day, the Q-SYMBIO dose range. For mitochondrial disease, fertility, migraine prophylaxis: 300–400 mg/day. Most users plateau on benefit above 400 mg/day."
      }
    },
    {
      "@type": "Question",
      "name": "Does CoQ10 improve sperm or egg quality?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes, with reasonable trial evidence in both male and female fertility. Multiple trials show CoQ10 supplementation improves sperm motility and concentration in subfertile men (200–400 mg/day for 3–6 months). Female fertility evidence is smaller but suggests improved ovarian response in older reproductive-age women, particularly during IVF cycles. The mechanism is mitochondrial — both eggs and sperm are exceptionally energy-demanding cells and sensitive to mitochondrial function."
      }
    },
    {
      "@type": "Question",
      "name": "Can I take CoQ10 with warfarin?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Talk to your prescribing clinician — CoQ10 has a structural similarity to vitamin K and can mildly reduce warfarin's anticoagulant effect. The interaction is modest but real, and INR monitoring is the practical safeguard. Most patients can stay on both with appropriate INR adjustment; some prescribers prefer to avoid the combination. Newer anticoagulants (apixaban, rivaroxaban) don't have this interaction."
      }
    }
  ]
};

const articleSchema = {
  "@context": "https://schema.org",
  "@type": "Article",
  "headline": "CoQ10: The Mitochondrial Cofactor With Heart Failure RCT Evidence",
  "description": "CoQ10 dosing, ubiquinol vs ubiquinone, the Q-SYMBIO heart failure trial, and statin myopathy support. Plus how it stacks with MOTS-c and longevity peptides.",
  "url": "https://profpeptide.com/supplements/coq10",
  "datePublished": "2026-04-07T00:00:00Z",
  "dateModified": "2026-05-26T00:00:00Z",
  "author": {
    "@type": "Organization",
    "name": "Prof. Peptide Editorial Team",
    "url": "https://profpeptide.com/about"
  },
  "reviewedBy": {
    "@type": "Organization",
    "name": "Prof. Peptide Editorial Team",
    "url": "https://profpeptide.com/about"
  },
  "publisher": {
    "@type": "Organization",
    "name": "Prof. Peptide",
    "url": "https://profpeptide.com"
  }
};

const breadcrumbSchema = {
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [
    { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://profpeptide.com" },
    { "@type": "ListItem", "position": 2, "name": "Supplements", "item": "https://profpeptide.com/supplements" },
    { "@type": "ListItem", "position": 3, "name": "CoQ10" }
  ]
};

export default function CoQ10Page() {
  return (
    <>
      <JsonLd data={articleSchema} />
      <JsonLd data={breadcrumbSchema} />
      <JsonLd data={faqPageSchema} />
    <div className="section max-w-3xl">
      <Link href="/supplements" className="text-sm text-[#0891b2] hover:underline mb-6 inline-block">&larr; Back to Supplement Library</Link>

      <div className="flex flex-wrap items-center gap-3 mb-2">
        <h1 className="text-3xl font-bold text-[#1e2d3d] dark:text-slate-100">CoQ10</h1>
        <span className="tag">Longevity</span>
      </div>
      <p className="text-sm text-gray-500 dark:text-slate-400 mb-2">
        Last reviewed: May 26, 2026
      </p>
      <div className="mb-8 p-4 bg-gray-50 dark:bg-[#1e293b] border border-gray-100 dark:border-slate-700 rounded-xl">
        <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
          <span className="font-semibold text-[#1e2d3d] dark:text-slate-100">Also Known As:</span> Coenzyme Q10, ubiquinol (reduced form), ubiquinone (oxidized form), CoQ, mitoquinol
        </p>
        <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed pt-1">
          <span className="font-semibold text-[#1e2d3d] dark:text-slate-100">Supplement Class:</span> Mitochondrial electron carrier / fat-soluble antioxidant / vitamin-like compound
        </p>
        <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed pt-1">
          <span className="font-semibold text-[#1e2d3d] dark:text-slate-100">Evidence Tier:</span> Strong — Q-SYMBIO heart failure RCT (Mortensen 2014, n=420, 2-year mortality reduction); KiSel-10 (Alehagen 2013, n=443, 54% CV mortality reduction over 4 years); Banach 2015 meta-analysis for statin myopathy; Lafuente 2013 meta-analysis for male fertility; hard cardiovascular-outcomes evidence unusually strong for a supplement
        </p>
      </div>

      <div id="overview" className="scroll-mt-20">
        <h2 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">What is CoQ10?</h2>
        <div className="space-y-4">
          <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
            Coenzyme Q10 (CoQ10) is a fat-soluble, vitamin-like compound present in virtually every cell of the human body — hence its alternate name, ubiquinone (from &ldquo;ubiquitous&rdquo;). It plays two irreplaceable roles: it&apos;s the essential mobile electron carrier in the mitochondrial electron transport chain (shuttling electrons between Complex I/II and Complex III to drive ATP synthesis), and in its reduced form (ubiquinol) it&apos;s one of the most important endogenous fat-soluble antioxidants. CoQ10 levels decline with age and are further reduced by statin medications — both via the shared HMG-CoA reductase / mevalonate pathway. The supplement evidence base is unusually strong: Q-SYMBIO (Mortensen 2014) demonstrated 2-year cardiovascular mortality reduction with 300 mg/day in heart failure patients, and KiSel-10 (Alehagen 2013) found CoQ10 + selenium reduced cardiovascular mortality by 54% in elderly adults over 4 years. Statin-myopathy evidence (Banach 2015 meta-analysis) is positive. CoQ10 pairs naturally with{" "}
            <Link href="/peptides/mots-c" className="text-[#0891b2] hover:underline">mitochondrial peptides like MOTS-c</Link>{" "}
            because the mechanisms operate on different layers of mitochondrial bioenergetics.
          </p>
          <div>
            <p className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">
              Reported benefits:
            </p>
            <ul className="list-disc list-inside space-y-1">
              <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Reduced cardiovascular mortality in chronic heart failure (Q-SYMBIO, 2-year follow-up)</li>
              <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">54% cardiovascular mortality reduction with CoQ10 + selenium in elderly (KiSel-10, 4-year follow-up)</li>
              <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Reduced statin-induced muscle symptoms (Banach 2015 meta-analysis)</li>
              <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Improved sperm concentration, motility, morphology in subfertile men (Lafuente 2013 meta-analysis)</li>
              <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Migraine prophylaxis — ~25–30% frequency reduction at 300 mg/day</li>
              <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Essential cofactor for mitochondrial ATP synthesis via electron transport chain</li>
              <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Fat-soluble antioxidant protecting mitochondrial membranes and circulating LDL</li>
            </ul>
          </div>
          <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
            <span className="font-semibold text-[#1e2d3d] dark:text-slate-100">Common dose:</span> 100–200 mg/day ubiquinol (or 200–300 mg ubiquinone) for general health and age-related maintenance; 300 mg/day ubiquinone for clinical heart failure adjunct (Q-SYMBIO protocol); 100–200 mg/day for statin myopathy; 300–400 mg/day for fertility, migraine, mitochondrial disease. Always with fat-containing meals.
          </p>
          <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
            <span className="font-semibold text-[#1e2d3d] dark:text-slate-100">Where to buy:</span> Available over-the-counter from supplement retailers. Quality varies — particularly around form (ubiquinol preferred for over-40 users) and oil-base softgel formulation. Review the quality-markers checklist in the Where to Buy section below.
          </p>
          <AmazonCTAButton href="https://www.amazon.com/s?k=CoQ10+ubiquinol&tag=profpeptide-20" label="CoQ10" />
        </div>
      </div>

      <PageTOC sections={tocSections} />

      <div className="space-y-8">
        {sections.map((s) => (
          <div key={s.id} id={s.id} className="scroll-mt-20">
            <h2 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">
              {s.title}
            </h2>
            {s.intro && (
              <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed mb-4">
                {s.intro}
              </p>
            )}
            {s.node && s.node}
            {s.body && (
              <ol className="list-decimal list-inside space-y-1">
                {s.body.map((item, i) => (
                  <li key={i} className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
                    {item}
                  </li>
                ))}
              </ol>
            )}
          </div>
        ))}
      </div>

      <div className="flex flex-wrap gap-2 mt-8">
        {["Mitochondria", "Heart Failure", "Statin Support", "Ubiquinol", "Electron Transport", "Fertility"].map((tag) => (
          <span key={tag} className="text-xs bg-gray-100 dark:bg-slate-700 text-gray-500 dark:text-slate-400 px-2.5 py-1 rounded-full">{tag}</span>
        ))}
      </div>

      <div className="mt-6 p-5 bg-gray-50 dark:bg-[#1e293b] border border-gray-100 dark:border-slate-700 rounded-xl">
        <h2 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">Related Supplements</h2>
        <div className="flex flex-wrap gap-4">
          <Link href="/supplements/nmn" className="text-sm font-medium text-[#0891b2] hover:underline">NMN</Link>
          <Link href="/supplements/nad-plus" className="text-sm font-medium text-[#0891b2] hover:underline">NAD+</Link>
          <Link href="/supplements/spermidine" className="text-sm font-medium text-[#0891b2] hover:underline">Spermidine</Link>
          <Link href="/supplements/resveratrol" className="text-sm font-medium text-[#0891b2] hover:underline">Resveratrol</Link>
          <Link href="/supplements/fish-oil" className="text-sm font-medium text-[#0891b2] hover:underline">Fish Oil</Link>
          <Link href="/supplements/magnesium" className="text-sm font-medium text-[#0891b2] hover:underline">Magnesium</Link>
        </div>
      </div>

      <PageDisclaimer />
    <ContactLink pageName="CoQ10" pagePath="/supplements/coq10" />
    </div>
    </>
  );
}
